Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

GLP1-based obesity medicines, such as Ozempic and Wegovy, have surged in popularity and become the subject of intense public debate.

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

In the video attached to this article we take a look at HIMS.

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

A weekly injection of diabetes medication could replace painful daily hormone shots for patients with a rare form of lipodystrophy.

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...